Yarrow Bioscience, Inc. (YARW)
Last updated: 2026-10-21 06:16:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
Yarrow Bioscience, Inc. (YARW) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $20.10, with a market capitalization of $168.61M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $18.05 to $44.28. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$168.61M | |
$19.87 | |
$44.28 | |
$18.05 | |
$19.98 | |
102.21K | |
97.74K | |
-- | |
$44.28 | |
$18.05 | |
-- | |
-- |
Yarrow Bioscience, Inc. (YARW) Latest Closing Stock Price
Yarrow Bioscience, Inc. (YARW) last closed at $19.98 as of 2026-10-20 23:31:00, unchanged from the previous close of $19.98.
During the latest regular trading session, YARW traded between $18.05 and $44.28, with a volume of 102.21K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Yarrow Bioscience, Inc. (YARW) 7-Day Stock Price Change
Over the past seven days, Yarrow Bioscience, Inc. (YARW) moved from $19.82 to $20.10, representing a gain of 1.41% ($0.28).
The stock traded between $18.05 and $20.58 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 122.88 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
YARW 52-Week Price Position
Position in Range: 7.8%
YARW is currently trading at $20.10, placing it 7.8% of the way from its 52-week low of $18.05 to its 52-week high of $44.28. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Yarrow Bioscience, Inc. (YARW)?
Yarrow Bioscience Inc is a clinical-stage biopharmaceutical company focused on developing biotherapeutics for autoimmune thyroid diseases. Its flagship product candidate, YB-101 (also known as GenSci098), is a humanized, monoclonal antibody targeting the thyroid-stimulating hormone receptor, which Yarrow plans to develop for the treatment of Graves' disease (GD) and potentially thyroid eye disease (TED). The company has one reportable segment relating to the research and development of its research programs, GD and TED.
Yarrow Bioscience, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Exchange | NASDAQ |
| Company Website |
How to Buy Yarrow Bioscience, Inc. (YARW) Stock on MEXC
Eligible investors can buy real shares of Yarrow Bioscience, Inc. (YARW) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Yarrow Bioscience, Inc. (YARW) stock price today?
2.Is YARW stock going up or down today?
3.What is YARW pre-market price?
4.What is YARW after-hours price?
5.Is YARW stock trading now?
6.Where does YARW sit relative to its 52-week high and low?
7.What sector is Yarrow Bioscience, Inc. in?
8.What is Yarrow Bioscience, Inc.'s market capitalization and where is it listed?
9.How is YARW valued in terms of P/E ratio and EPS?
10.Does Yarrow Bioscience, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
YARW Stock Calculator
Estimate the value between YARW shares and USD.
YARW Shares to USD
1.00 YARW shares = 20.099 USD
Calculations are estimates based on the latest available price and are for reference only.


